On March 11, 2019 RedHill Biopharma Ltd. (Nasdaq: RDHL) (Tel-Aviv Stock Exchange: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company primarily focused on gastrointestinal (GI) diseases, reported that Mr. Adi Frish, senior vice president of business development and licensing, will present a corporate overview at the 31st Annual ROTH Conference on Tuesday, March 19, 2019, at 1:00 p.m. PDT at the Ritz-Carlton, Laguna Niguel in Dana Point, CA (Press release, RedHill Biopharma, MAR 11, 2019, View Source [SID1234534222]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The presentation will be broadcast live and available via replay for 30 days on the Company’s website, View Source Please access the website at least 15 minutes ahead of the conference call to register.